US Senate backing for Canadian imports

October 29, 2003

The US Senate has backed a limited scheme to allow the parallel importation of drugs from Canada in order to …

GSK resumes talks on pay

October 29, 2003

First new HIV drug in seven years gets approval

October 29, 2003

The first novel HIV treatment in seven years, Roche Fuzeon, is to undergo fast track approval in the US.Fuzeon was …

New ministerial team unveiled at Department of Health

October 29, 2003

The Government has used the unexpected departure of Alan Milburn to bring in four new ministers to head the Department …

Doctors shutting out sales reps

October 29, 2003

Doctors are making a conscious decision to give up less of their time to see sales reps, according to a …

NHS targets to flourish under ‘arch moderniser

October 29, 2003

New Health Secretary Dr John Reid has committed the NHS to continued reform despite a growing chorus of disapproval over …

AZ settles $355m fraud case

October 29, 2003

AstraZeneca has settled the case relating to fraudulent sales of its prostate cancer drug Zoladex, and will pay a total …

Department of Health takes a dose of its own medicine

October 29, 2003

The Department of Health is to open itself up to the same adical transformationit is overseeing in the NHS by …

Final battle for future of US healthcare draws near

October 29, 2003

The future of the US healthcare system and how patients pay for their medicines will be decided in the coming …

Pfizer cool on Prilosec OTC launch

October 29, 2003

Pfizer has criticised the US approval of an over-the-counter formulation of AstraZeneca's heartburn drug Prilosec, saying it will only serve …

Biotech consolidation picks up with $6.4bn deal

October 29, 2003

The recent run of biotech consolidation has stepped up a gear as Biogen and Idec have agreed a $6.4 billion …

Foundation status reform not most important, say trusts

October 29, 2003

The Government's plans for foundations hospitals will have much less impact on the NHS than other reforms of the health …

Novartis buys Pfizer incontinence drug

October 29, 2003

Novartis has bought Pfizer's incontinence product Enablex ahead of the US giant's merger with Pharmacia.The drug is one of several …

Look closer – The importance of local opinion leaders

October 29, 2003
Sales and Marketing key opinion leaders

There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …

The Gateway to Local Adoption Series

Latest content